Stocktoria
Tenaya Therapeutics, Inc. TNYA
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2021-07-30
Chart by TradingView
3/9
Piotroski F — financial health
-8.2
Altman Z″ — distress risk · distress
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$93.3M | -$115.9M | -$131.2M | -$125.6M | -$72.8M |
| Net income | -$90.6M | -$111.1M | -$124.1M | -$123.7M | -$72.7M |
| Operating cash flow | -$68.3M | -$90.5M | -$102.1M | -$104.4M | -$60.8M |
| Free cash flow | -$68.9M | -$91.5M | -$103.3M | -$125.1M | -$85.9M |
| Total assets | $146.9M | $119.9M | $170.5M | $278.9M | $314.2M |
| Total liabilities | $23.7M | $27.1M | $31.1M | $35.6M | $35.7M |
| Shareholders' equity | $123.3M | $92.9M | $139.4M | $243.4M | $278.5M |
| Ratios | |||||
| Return on assets | -61.7% | -92.7% | -72.8% | -44.3% | -23.1% |
| Return on equity | -73.5% | -119.7% | -89.0% | -50.8% | -26.1% |
| Current ratio | 6.84 | 4.22 | 4.91 | 7.99 | 11.73 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 3,713,761 | $2.6M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: -8.2 (distress)
- Working capital / assets 0.614
- Retained earnings / assets -4.118
- EBIT / assets -0.635
- Equity / liabilities 5.211
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001858848 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.